Company Filing History:
4 out of 559 
3 out of 5,450 
1 out of 11 Years Active: 2014-2019
Title: The Innovative Contributions of Padmanee Sharma
Introduction
Padmanee Sharma is a prominent inventor based in Bellaire, TX (US), known for his significant contributions to cancer immunotherapy. With a total of 4 patents, he has made remarkable strides in the field of oncology, particularly in developing combination therapies that enhance the immune response against tumors.
Latest Patents
Among his latest patents, Sharma has developed a groundbreaking approach to cancer treatment. His work on combination immunotherapy involves the use of agonists to ICOS in conjunction with blocking agents targeting T cell inhibitory receptors, such as CTLA-4 and PD-1. This innovative method has shown promise in effectively treating various tumors, marking a significant advancement in cancer therapy.
Career Highlights
Throughout his career, Padmanee Sharma has been associated with prestigious institutions, including Memorial Sloan Kettering Cancer Center and the University of Texas System. His work in these organizations has allowed him to collaborate with leading experts in the field and contribute to cutting-edge research in cancer treatment.
Collaborations
Sharma has worked alongside notable colleagues, including James Patrick Allison and Sergio A Quezada. These collaborations have further enriched his research and have played a crucial role in advancing the understanding of immunotherapy.
Conclusion
Padmanee Sharma's innovative work in cancer immunotherapy exemplifies the impact of dedicated research and collaboration in the fight against cancer. His contributions continue to inspire advancements in medical science and offer hope for improved treatment options for patients.